New Meningitis Vaccine

Question: I have heard from my child’s middle school that there is a new meningitis vaccine. Do my children need it? Can you tell me more?

 Answer: There is a new meningitis vaccine called Menactra that has been approved by the FDA to prevent a disease called meningococcal meningitis.  It is formulated to be given to individuals between the ages of 2 and 55. The Center for Disease Control (CDC) now recommends the vaccine to all children at their routine pre-adolescent visit (11 – 12 years of age).  For those who have never gotten the vaccine before, a dose is recommended at high school entry. The vaccine is also recommended for college freshmen, especially if they are living in dormitories. Many schools and colleges require that the vaccine be given prior to admission, so you might want to check with your local school district. Because Menactra provides long lasting immunity, one vaccination can protect your middle school child into his or her college years. For older adults, meningitis vaccine is recommended by the CDC to protect travelers going to certain countries where meningitis is prevalent. Menactra can be given to travelers who are under 55, and the old vaccine formulation, Menomune, is still available to travelers over 55. Call us to discuss this in greater detail and to schedule an appointment for your vaccines.